URGN Cash & Short-Term Investments
Urogen Pharma Ltd · Cash & Short-Term Investments
URGN Cash & Short-Term Investments
Latest reported$120.46Mperiod ending
URGN FY Cash & Short-Term Investments ($3.04M → $120.46M)
Annual Cash & Short-Term Investments
High-resolution chart · PNG
URGN cash & short-term investments history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Short-Term Investments (USD) |
|---|---|
| 120,456,000 | |
| 236,685,000 | |
| 136,968,000 | |
| 99,964,000 | |
| 89,139,000 | |
| 102,018,000 | |
| 147,077,000 | |
| 101,318,000 | |
| 73,000,000 | |
| 21,362,000 | |
| 17,975,000 | |
| 3,870,000 | |
| 3,037,000 |